Kaseta Michael insider trades
Kaseta Michael has filed 47 Form 4s with the SEC that we hold, for Liquidia Corp (LQDA) (CFO and COO), Heron Therapeutics, INC. /DE/ (HRTX) (Director) and ALIM (Director). Across all of them we count 4 purchases worth $132.3K and 31 sales worth $18.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 13 sales ($16.2M). The largest single trade was a sale of 133,789 shares of Liquidia Corp worth $5.4M, dated 2026-04-09. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-23 and the latest 2026-10-13.
Liquidia Corp (LQDA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-05-31 | P, purchase reported on Form 4 | 13,639 | $54.7K | 2022-06-01 | SEC |
| 2022-05-31 | P, purchase reported on Form 4 | 5,061 | $20.2K | 2022-06-01 | SEC |
| 2022-08-31 | P, purchase reported on Form 4 | 1,927 | $9.4K | 2022-09-01 | SEC |
| 2022-09-13 | P, purchase reported on Form 4 | 8,000 | $47.9K | 2022-09-14 | SEC |
| 2024-03-18 | S, sale reported on Form 4 | 11,315 | $179.0K | 2024-03-19 | SEC |
| 2024-03-18 | S, sale reported on Form 4 | 851 | $13.5K | 2024-03-19 | SEC |
| 2024-04-12 | S, sale reported on Form 4 | 3,136 | $45.7K | 2024-04-16 | SEC |
| 2024-06-03 | S, sale reported on Form 4 | 1,094 | $15.9K | 2024-06-04 | SEC |
| 2024-07-12 | S, sale reported on Form 4 | 3,906 | $48.9K | 2024-07-15 | SEC |
| 2024-09-03 | S, sale reported on Form 4 | 1,079 | $10.3K | 2024-09-04 | SEC |
| 2024-10-14 | S, sale reported on Form 4 | 3,892 | $43.2K | 2024-10-15 | SEC |
| 2024-12-02 | S, sale reported on Form 4 | 1,091 | $12.6K | 2024-12-03 | SEC |
| 2025-01-14 | S, sale reported on Form 4 | 23,370 | $275.3K | 2025-01-14 | SEC |
| 2025-03-03 | S, sale reported on Form 4 | 874 | $13.5K | 2025-03-04 | SEC |
| 2025-04-14 | S, sale reported on Form 4 | 8,283 | $112.4K | 2025-04-16 | SEC |
| 2025-06-02 | S, sale reported on Form 4 | 859 | $14.4K | 2025-06-03 | SEC |
| 2025-06-04 | S, sale reported on Form 4 | 14,777 | $250.8K | 2025-06-05 | SEC |
| 2025-07-14 | S, sale reported on Form 4 | 11,580 | $165.4K | 2025-07-15 | SEC |
| 2025-08-05 | S, sale reported on Form 4 | 30,000 | $600.0K | 2025-08-07 | SEC |
| 2025-08-15 | S, sale reported on Form 4 | 20,000 | $523.6K | 2025-08-19 | SEC |
| 2025-09-02 | S, sale reported on Form 4 | 1,148 | $33.3K | 2025-09-03 | SEC |
| 2025-10-13 | S, sale reported on Form 4 | 11,630 | $272.3K | 2025-10-15 | SEC |
| 2025-12-01 | S, sale reported on Form 4 | 1,166 | $37.5K | 2025-12-02 | SEC |
| 2026-01-12 | S, sale reported on Form 4 | 36,932 | $1.4M | 2026-01-13 | SEC |
| 2026-03-02 | S, sale reported on Form 4 | 1,165 | $35.6K | 2026-03-03 | SEC |
| 2026-04-09 | S, sale reported on Form 4 | 133,789 | $5.4M | 2026-04-13 | SEC |
| 2026-04-10 | S, sale reported on Form 4 | 23,821 | $956.2K | 2026-04-14 | SEC |
| 2026-04-13 | S, sale reported on Form 4 | 18,958 | $727.4K | 2026-04-14 | SEC |
| 2026-04-14 | S, sale reported on Form 4 | 3,000 | $120.0K | 2026-04-16 | SEC |
| 2026-04-15 | S, sale reported on Form 4 | 9,044 | $363.0K | 2026-04-16 | SEC |
| 2026-04-15 | S, sale reported on Form 4 | 86,971 | $3.5M | 2026-04-16 | SEC |
| 2026-04-15 | S, sale reported on Form 4 | 43,375 | $1.7M | 2026-04-16 | SEC |
| 2026-07-13 | S, sale reported on Form 4 | 1,453 | $103.7K | 2026-07-14 | SEC |
| 2026-07-13 | S, sale reported on Form 4 | 18,977 | $1.4M | 2026-07-14 | SEC |
| 2026-10-12 | S, sale reported on Form 4 | 18,938 | $539.4K | 2026-10-13 | SEC |
Heron Therapeutics, INC. /DE/ (HRTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ALIM
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1724346) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
